High Free Cash Flow Stocks
DGX is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
QUEST DIAGNOSTICS INC (DGX) Stock Price & Overview
NYSE:DGX • US74834L1008
Current stock price
198.02 USD
+0.33 (+0.17%)
At close:
198.02 USD
0 (0%)
After Hours:
The current stock price of DGX is 198.02 USD. Today DGX is up by 0.17%. In the past month the price decreased by -2.92%. In the past year, price increased by 20.61%.
DGX Key Statistics
52-Week Range157.2 - 213.5
Current DGX stock price positioned within its 52-week range.
1-Month Range192.73 - 205
Current DGX stock price positioned within its 1-month range.
- Market Cap
- 21.756B
- P/E
- 20.10
- Fwd P/E
- 18.44
- EPS (TTM)
- 9.85
- Dividend Yield
- 1.74%
DGX Stock Performance
Today
+0.17%
1 Week
-0.07%
1 Month
-2.92%
3 Months
+13.94%
Longer-term
6 Months +10.42%
1 Year +20.61%
2 Years +43.31%
3 Years +42.66%
5 Years +50.15%
10 Years +163.43%
DGX Stock Chart
DGX Stock Screens
DGX currently appears in the following ChartMill screener lists.
DGX Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to DGX. When comparing the yearly performance of all stocks, DGX is one of the better performing stocks in the market, outperforming 71.33% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
DGX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to DGX. DGX scores excellent on profitability, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
DGX Earnings
On February 10, 2026 DGX reported an EPS of 2.42 and a revenue of 2.81B. The company beat EPS expectations (1.51% surprise) and beat revenue expectations (0.9% surprise).
Next Earnings DateApr 21, 2026
Last Earnings DateFeb 10, 2026
PeriodQ4 / 2025
EPS Reported$2.42
Revenue Reported2.806B
EPS Surprise 1.51%
Revenue Surprise 0.90%
DGX Forecast & Estimates
24 analysts have analysed DGX and the average price target is 220.47 USD. This implies a price increase of 11.34% is expected in the next year compared to the current price of 198.02.
For the next year, analysts expect an EPS growth of 9.04% and a revenue growth 6.96% for DGX
Analysts
Analysts75.83
Price Target220.47 (11.34%)
EPS Next Y9.04%
Revenue Next Year6.96%
DGX Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Services DGX Financial Highlights
Over the last trailing twelve months DGX reported a non-GAAP Earnings per Share(EPS) of 9.85. The EPS increased by 9.2% compared to the year before.
Income Statements
Revenue(TTM)11.04B
Net Income(TTM)988.00M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.95% | ||
| ROA | 6.09% | ||
| ROE | 13.78% | ||
| Debt/Equity | 0.72 |
Chartmill High Growth Momentum
EPS Q2Q%3.86%
Sales Q2Q%7.06%
EPS 1Y (TTM)9.2%
Revenue 1Y (TTM)11.78%
DGX Ownership
Ownership
Inst Owners100.18%
Shares109.87M
Float109.35M
Ins Owners0.31%
Short Float %3.54%
Short Ratio3.88
DGX Competitors/Peers
The largest stocks on the US markets in the "Health Care Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.13 | 93.495B | ||
| CI | THE CIGNA GROUP | 8.64 | 71.194B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 103.73 | 27.674B | ||
| LH | LABCORP HOLDINGS INC | 14.98 | 22.555B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.308B | ||
| DVA | DAVITA INC | 10.29 | 9.725B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.08 | 8.291B | ||
| CHE | CHEMED CORP | 15.69 | 5.241B | ||
| AGL | AGILON HEALTH INC | N/A | 4.456B | ||
| HIMS | HIMS & HERS HEALTH INC | 35.05 | 4.363B | ||
| OPCH | OPTION CARE HEALTH INC | 14.4 | 4.298B | ||
| RDNT | RADNET INC | 68.87 | 4.252B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About DGX
Company Profile
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Company Info
IPO: 1996-12-17
QUEST DIAGNOSTICS INC
500 Plaza Drive
Secaucus NEW JERSEY 07094 US
CEO: Stephen H. Rusckowski
Employees: 46000
Phone: 13026587581
QUEST DIAGNOSTICS INC / DGX FAQ
Can you describe the business of QUEST DIAGNOSTICS INC?
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 46,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
What is the stock price of QUEST DIAGNOSTICS INC today?
The current stock price of DGX is 198.02 USD. The price increased by 0.17% in the last trading session.
Does DGX stock pay dividends?
QUEST DIAGNOSTICS INC (DGX) has a dividend yield of 1.74%. The yearly dividend amount is currently 3.19.
How is the ChartMill rating for QUEST DIAGNOSTICS INC?
DGX has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists DGX stock?
DGX stock is listed on the New York Stock Exchange exchange.
What is the analyst forecast for DGX stock?
24 analysts have analysed DGX and the average price target is 220.47 USD. This implies a price increase of 11.34% is expected in the next year compared to the current price of 198.02.
Who owns QUEST DIAGNOSTICS INC?
You can find the ownership structure of QUEST DIAGNOSTICS INC (DGX) on the Ownership tab.